中文Melanoma is a rare and serious dermatological malignancy, which often arises from junctional nevus or mixed nevus, and most intradermal nevi do not undergo malignant transformation. Although the incidence of melanoma in China is relatively low, due to its high severity, attention should also be paid to it, so as to facilitate "early detection and early treatment" and effectively improve the prognosis of treatment. As for why moles turn into dangerous cancers, the specific reason is not clear, but it is inseparable from factors such as excessive exposure to ultraviolet rays.
Now trametinib targeted drug is about 2200 yuan a box and a bottle for a month. The latest medical insurance price news of trametinib in 2023 is about 2200 yuan a box and a bottle for a month
After the diagnosis, patients should receive treatment immediately. Most of the early patients can be surgically resected to obtain good curative effect. However, because melanoma is prone to metastasis, many patients are unable to receive surgical treatment when they are diagnosed for the first time. For patients with unresectable melanoma, targeted therapy has been widely used. Trametinib is one of the targeted drugs currently on the market for the treatment of melanoma. After gaining a certain understanding of trametinib, many patients will also find that it has been successfully marketed in countries such as Laos. So how much is the Lao version of trametinib? How about its curative effect?
It is understood that since trametinib was launched on the market, a large number of clinical studies have confirmed that its combination therapy with dabrafenib can prolong the survival of patients with melanoma and anaplastic thyroid cancer. Therefore, in 2018, it was approved by the US FDA for marketing in combination with dabrafenib for the treatment of anaplastic thyroid cancer caused by BRAF V600E gene abnormalities. In addition, dual-target therapy has also been approved for the treatment of melanoma and non-small cell lung cancer caused by BRAF mutations.
How much is the Lao version of Trametinib? It is reported that the Lao version of trametinib is produced by a local regular pharmaceutical company, Lao Nanta Big Bear. It has been on the market for many years, and the price has also undergone many changes. Recently updated price information shows that the price of the Lao version of trametinib with a specification of 2mg*30 capsules is around 2,200 yuan.